FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Baxter Recalls 2 Lots of Dual Luer Lock Caps

[ Price : $8.95]

Baxter International recalls two lots of its Dual Luer Lock Caps because of the presence of loose particulate matter found in the ...

FDA Panel Backs ReSure Cataract Surgery Sealant

[ Price : $8.95]

FDAs Ophthalmic Devices Panel votes that an Ocular Therapeutix PMA for ReSure Sealant is safe and effective for managing clear cor...

Phase 3 Study with GSKs Oligonucleotide Misses Endpoint

[ Price : $8.95]

A GlaxoSmithKline and Prosensa Phase 3 clinical study involving drisapersen, misses the primary endpoint.

FTC Plans Workshop on Native Advertising

[ Price : $8.95]

The Federal Trade Commission plans a 12/4 workshop to examine the practice of blending advertisements with news, entertainment, an...

FDA Issues Report on Chronic Fatigue Meeting

[ Price : $8.95]

FDA issues a report summarizing the presentations and discussion at a PDUFA 5 Voice of the Patient public meeting on chronic fatig...

Medical Device Single Audit Pilot Begins January

[ Price : $8.95]

CDRH international affairs associate director Kim Trautman updates an industry conference on a Center-backed medical device single...

FDA Publishes Safety Evaluation Summary

[ Price : $8.95]

FDA publishes a summary of its safety evaluation of drugs and biologics from April to June.

CDER Science Chief Webber Retires to Join Perrigo

[ Price : $8.95]

CDER Office of Pharmaceutical Science acting director Keith Webber retires to accept a position with Perrigo effective 10/18.

FDA Approves Teva sNDA for Liquid Treanda

[ Price : $8.95]

FDA approves a Teva Pharmaceutical Industries supplemental NDA for Treanda (bendamustine HCI) injection in a new liquid formulatio...

Changes Sought in Pediatric Study Plan Guidance

[ Price : $8.95]

BIO asks FDA for an optional more comprehensive approach to pediatric drug development.